FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135298509> ?p ?o ?g. }

• W2135298509 endingPage "32" @default.
• W2135298509 startingPage "32" @default.
• W2135298509 abstract "Tumor-associated lymphocyte numbers in breast cancer have been suggested as a new independent predictor of response to neoadjuvant chemotherapy in breast cancer patients. We therefore evaluated the relationship between pathologic complete response (pCR) and tumor-associated lymphocytes in tumors of such patients.Between 2000 and 2009, we retrospectively evaluated 175 patients with primary breast cancer treated with neoadjuvant chemotherapy, followed by definitive surgical resection. Peritumoral lymphocytic infiltration (LI) and CD3(+), CD8(+), and forkhead box P3 (FOXP3)(+) lymphocytes were assessed in pretreatment biopsy specimens.Nineteen (11%) patients achieved pCR. An elevated LI, CD3(+), CD8(+), or FOXP3(+) lymphocytic infiltration; lower clinical T stage; human epidermal growth factor receptor 2 overexpression; and herceptin-based treatment were all significantly associated with pCR. Through a multivariate analysis, LI (odds ratio [OR], 1.26; p=0.024), clinical T stage (OR, 3.06; p=0.041), and the use of a herceptin-based regimen (OR, 4.95; p=0.004) were all significant independent predictors of pCR. Significantly higher numbers of tumor-associated lymphocytes and CD3(+), CD8(+), and FOXP3(+) T-cells were observed in the following: high-grade tumors, tumors of positive nodal status, and tumors negative for hormone receptors.Tumor-associated lymphocytes are significantly associated with pCR, suggesting that tumor-associated lymphocytes may be an important pathological factor predicting a response to neoadjuvant chemotherapy in breast cancer patients." @default.
• W2135298509 created "2016-06-24" @default.
• W2135298509 creator A5007992707 @default.
• W2135298509 creator A5010518834 @default.
• W2135298509 creator A5032349144 @default.
• W2135298509 creator A5070644681 @default.
• W2135298509 creator A5073608158 @default.
• W2135298509 date "2013-01-01" @default.
• W2135298509 modified "2023-10-01" @default.
• W2135298509 title "Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients" @default.
• W2135298509 cites W1661544713 @default.
• W2135298509 cites W1955397179 @default.
• W2135298509 cites W1970580356 @default.
• W2135298509 cites W1979250236 @default.
• W2135298509 cites W1979379635 @default.
• W2135298509 cites W2001498331 @default.
• W2135298509 cites W2006983673 @default.
• W2135298509 cites W2013920437 @default.
• W2135298509 cites W2022205756 @default.
• W2135298509 cites W2031576122 @default.
• W2135298509 cites W2036294483 @default.
• W2135298509 cites W2036383793 @default.
• W2135298509 cites W2047902191 @default.
• W2135298509 cites W2068920468 @default.
• W2135298509 cites W2082462313 @default.
• W2135298509 cites W2083803850 @default.
• W2135298509 cites W2083991703 @default.
• W2135298509 cites W2088160256 @default.
• W2135298509 cites W2092918797 @default.
• W2135298509 cites W2104528117 @default.
• W2135298509 cites W2105459360 @default.
• W2135298509 cites W2136757504 @default.
• W2135298509 cites W2137074525 @default.
• W2135298509 cites W2137942213 @default.
• W2135298509 cites W2140633375 @default.
• W2135298509 cites W2157058802 @default.
• W2135298509 cites W2162760540 @default.
• W2135298509 cites W2164540420 @default.
• W2135298509 cites W74043092 @default.
• W2135298509 doi "https://doi.org/10.4048/jbc.2013.16.1.32" @default.
• W2135298509 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3625767" @default.
• W2135298509 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23593079" @default.
• W2135298509 hasPublicationYear "2013" @default.
• W2135298509 type Work @default.
• W2135298509 sameAs 2135298509 @default.
• W2135298509 citedByCount "112" @default.
• W2135298509 countsByYear W21352985092013 @default.
• W2135298509 countsByYear W21352985092014 @default.
• W2135298509 countsByYear W21352985092015 @default.
• W2135298509 countsByYear W21352985092016 @default.
• W2135298509 countsByYear W21352985092017 @default.
• W2135298509 countsByYear W21352985092018 @default.
• W2135298509 countsByYear W21352985092019 @default.
• W2135298509 countsByYear W21352985092020 @default.
• W2135298509 countsByYear W21352985092021 @default.
• W2135298509 countsByYear W21352985092022 @default.
• W2135298509 countsByYear W21352985092023 @default.
• W2135298509 crossrefType "journal-article" @default.
• W2135298509 hasAuthorship W2135298509A5007992707 @default.
• W2135298509 hasAuthorship W2135298509A5010518834 @default.
• W2135298509 hasAuthorship W2135298509A5032349144 @default.
• W2135298509 hasAuthorship W2135298509A5070644681 @default.
• W2135298509 hasAuthorship W2135298509A5073608158 @default.
• W2135298509 hasBestOaLocation W21352985091 @default.
• W2135298509 hasConcept C121608353 @default.
• W2135298509 hasConcept C126322002 @default.
• W2135298509 hasConcept C142724271 @default.
• W2135298509 hasConcept C143998085 @default.
• W2135298509 hasConcept C167672396 @default.
• W2135298509 hasConcept C203014093 @default.
• W2135298509 hasConcept C2776694085 @default.
• W2135298509 hasConcept C2777701055 @default.
• W2135298509 hasConcept C2778292576 @default.
• W2135298509 hasConcept C2778326572 @default.
• W2135298509 hasConcept C2779727006 @default.
• W2135298509 hasConcept C530470458 @default.
• W2135298509 hasConcept C71924100 @default.
• W2135298509 hasConcept C8891405 @default.
• W2135298509 hasConceptScore W2135298509C121608353 @default.
• W2135298509 hasConceptScore W2135298509C126322002 @default.
• W2135298509 hasConceptScore W2135298509C142724271 @default.
• W2135298509 hasConceptScore W2135298509C143998085 @default.
• W2135298509 hasConceptScore W2135298509C167672396 @default.
• W2135298509 hasConceptScore W2135298509C203014093 @default.
• W2135298509 hasConceptScore W2135298509C2776694085 @default.
• W2135298509 hasConceptScore W2135298509C2777701055 @default.
• W2135298509 hasConceptScore W2135298509C2778292576 @default.
• W2135298509 hasConceptScore W2135298509C2778326572 @default.
• W2135298509 hasConceptScore W2135298509C2779727006 @default.
• W2135298509 hasConceptScore W2135298509C530470458 @default.
• W2135298509 hasConceptScore W2135298509C71924100 @default.
• W2135298509 hasConceptScore W2135298509C8891405 @default.
• W2135298509 hasIssue "1" @default.
• W2135298509 hasLocation W21352985091 @default.
• W2135298509 hasLocation W21352985092 @default.
• W2135298509 hasLocation W21352985093 @default.
• W2135298509 hasLocation W21352985094 @default.
• W2135298509 hasOpenAccess W2135298509 @default.

• next